The cGAS-STING pathway: a therapeutic target in diabetes and its complications
Burns & Trauma · 01.01.2024 · 12
DOI: 10.1093/burnst/tkad050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Burns & Trauma, online erschienen am 02.02.2024. Verfasst von Wenjie He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Lab of the Basic Pharmacology of the Ministry of Education, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, Ch…. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 343 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Natural Science Foundation, Outstanding Young Scientific and Technological Talents Project of Guizhou Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic wound healing (DWH) represents a major complication of diabetes where inflammation is a key impediment to proper healing. The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has emerged as a central mediator of inflammatory responses to cell stress and damage. However, the contribution of cGAS-STING activation to impaired healing in DWH remains understudied. In this review, we examine the evidence that cGAS-STING-driven inflammation is a critical factor underlying defective DWH. We summarize studies revealing upregulation of the cGAS-STING pathway in diabetic wounds and discuss how this exacerbates inflammation and senescence and disrupts cellular metabolism to block healing. Partial pharmaceutical inhibition of cGAS-STING has shown promise in damping inflammation and improving DWH in preclinical models. We highlight key knowledge gaps regarding cGAS-STING in DWH, including its relationships with endoplasmic reticulum stress and metal-ion signaling. Elucidating these mechanisms may unveil new therapeutic targets within the cGAS-STING pathway to improve healing outcomes in DWH. This review synthesizes current understanding of how cGAS-STING activation contributes to DWH pathology and proposes future research directions to exploit modulation of this pathway for therapeutic benefit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Lab of the Basic Pharmacology of the Ministry of Education, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, China.
- College of Pharmacy, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, China.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
- Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, China.
ORCID-Profile: Wenjie He, Xingqian Wu, Yiqiu Liu
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Natural Science Foundation
- Outstanding Young Scientific and Technological Talents Project of Guizhou Province
- China Scholarship Council
Zitieren
APA
He, W., Mu, X., Wu, X., Liu, Y., Deng, J., Liu, Y., Han, F., & Nie, X. (2024). The cGAS-STING pathway: a therapeutic target in diabetes and its complications. Burns & Trauma, 12. https://doi.org/10.1093/burnst/tkad050
Vancouver
He W, Mu X, Wu X, Liu Y, Deng J, Liu Y, et al. The cGAS-STING pathway: a therapeutic target in diabetes and its complications. Burns & Trauma. 2024;12. doi:10.1093/burnst/tkad050
BibTeX
@article{He2024,
author = {He, Wenjie and Mu, Xingrui and Wu, Xingqian and Liu, Ye and Deng, Junyu and Liu, Yiqiu and Han, Felicity and Nie, Xuqiang},
title = {The cGAS-STING pathway: a therapeutic target in diabetes and its complications},
journal = {Burns & Trauma},
year = {2024},
volume = {12},
doi = {10.1093/burnst/tkad050}
}
EUVIMED